Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Smith-Jones

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2005
Radioimmunotherapy of prostate cancerP M Smith-Jones
Lancet (London, England)|August 16, 1997
Interferon-gamma for respiratory diseasesP M Smith-Jones, W Linkesch, I Virgolini
Acta Radiologica. Supplementum|January 1, 1991
Production of longer-lived positron emitters at the Paul Scherrer InstituteR Weinreich, R Schwarzbach, I Huszar, et al.
Nuclear Medicine and Biology|January 15, 1998
Synthesis, biodistribution and renal handling of various chelate-somatostatin conjugates with metabolizable linking groupsP M Smith-Jones, B Stolz, R Albert, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1994
Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumorsB Stolz, P M Smith-Jones, R Albert, et al.
European Journal of Nuclear Medicine|July 15, 1998
The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumoursB Stolz, G Weckbecker, P M Smith-Jones, et al.
Nuclear Medicine and Biology|June 10, 1998
Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumoursP M Smith-Jones, B Stolz, R Albert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studiesP M Smith-Jones, B Stolz, C Bruns, et al.
Bioconjugate Chemistry|November 1, 1991
Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acidP M Smith-Jones, R Fridrich, T A Kaden, et al.
Cancer Research|October 4, 2000
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigenP M Smith-Jones, S Vallabahajosula, S J Goldsmith, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2005
Radioimmunotherapy of prostate cancerP M Smith-Jones
Lancet (London, England)|August 16, 1997
Interferon-gamma for respiratory diseasesP M Smith-Jones, W Linkesch, I Virgolini
Acta Radiologica. Supplementum|January 1, 1991
Production of longer-lived positron emitters at the Paul Scherrer InstituteR Weinreich, R Schwarzbach, I Huszar, et al.
Nuclear Medicine and Biology|January 15, 1998
Synthesis, biodistribution and renal handling of various chelate-somatostatin conjugates with metabolizable linking groupsP M Smith-Jones, B Stolz, R Albert, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 1, 1994
Biological characterisation of [67Ga] or [68Ga] labelled DFO-octreotide (SDZ 216-927) for PET studies of somatostatin receptor positive tumorsB Stolz, P M Smith-Jones, R Albert, et al.
European Journal of Nuclear Medicine|July 15, 1998
The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumoursB Stolz, G Weckbecker, P M Smith-Jones, et al.
Nuclear Medicine and Biology|June 10, 1998
Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumoursP M Smith-Jones, B Stolz, R Albert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1994
Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studiesP M Smith-Jones, B Stolz, C Bruns, et al.
Bioconjugate Chemistry|November 1, 1991
Antibody labeling with copper-67 using the bifunctional macrocycle 4-[(1,4,8,11-tetraazacyclotetradec-1-yl)methyl]benzoic acidP M Smith-Jones, R Fridrich, T A Kaden, et al.
Cancer Research|October 4, 2000
In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigenP M Smith-Jones, S Vallabahajosula, S J Goldsmith, et al.
Pageof 2